Skip to content

Guided bone regeneration of peri-implant defects with particulate versus soft-type block bone substitutes. A randomized controlled, single blinded clinical trial

Guided bone regeneration of peri-implant defects with particulate versus soft-type block bone substitutes. A randomized controlled, single blinded clinical trial - L-Shape

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020222
Enrollment
64
Registered
2020-06-15
Start date
2021-03-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K00-K14

Interventions

Group 1: Placement of the implant simultaneously with L-shaped deproteinized bovine-derived bone mineral with 10% of Collagen and a collagen membrane Group 2: Placement of the implant simultaneously w

Sponsors

Clinic of Reconstructive DentistryCenter of Dental MedicineUniversity of Zürich
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients, in need of at least one implant with an expected peri-implant bone dehiscence = 2 mm of apico-coronal dimension in the maxilla or mandible (excl. molars) -primary implant stability assessed at implant placement -no need of soft tissue grafting after implant placement -tooth extraction performed = 4 months in advance -possibly performed soft tissue grafting = 2 months in advance -Presence of one adjacent tooth at the implant site; -Presence of antagonist; -Adequate oral hygiene (Bleeding on probing <20%; Plaque index <20%); -Capability to comply with the study procedures -Signed Informed Consent Form

Exclusion criteria

Exclusion criteria: -Ridge preservation procedure after tooth extraction performed -Pregnant or lactating women; -Known or suspected non-compliance, drug or alcohol abuse -Smokers (>10 cigarettes/day including e-cigarettes) -Currently taking drugs that influence bone metabolism -Use of bisphosphonates in the last 4 years -Systemic or local conditions presenting a contraindication to implant treatment -History of malignancy, radiotherapy or chemotherapy for malignancy in the past 5 years

Design outcomes

Primary

MeasureTime frame
Change of horizontal bone thickness at the level of the implant shoulder of the augmented region between baseline (implant placement) and 6 months visit, measured by CBCT

Secondary

MeasureTime frame
-marginal bone level (implant shoulder to first bone-to-implant-contact) at baseline, 6 months, 1 year, 3 and 5 years, by radiographs - Implant survival at 6 months, 1 year, 3 and 5 years by visual observation - horizontal bone thickness at the level of the implant shoulder of the augmented area at 6 months, 1 year, 3 and 5 years by CBCT - vertical defect fill at implant placement, at 6 months and at 5 years by radiographs - soft tissue volume at the area of interest at implant placement, at 6 months, 1 years, 3 and 5 years by volumetric analysis of the digital impressions - PD, REC and KT, PI, BOP, MML at Baseline, 6 months, 1 year, 3 and 5 years) by probing - PES: evaluator rating at final reconstruction, 1 year, 3 and 5 years -Patient reported outcomes (OHIP questionnaire, general rating of outcome) at 6 months, final reconstruction, 1 year,3 and 5 years -Prosthetic outcomes by USPHS

Countries

Spain, Switzerland

Contacts

Public ContactRonald Jung

Clinic of Reconstructive Dentistry Center of Dental Medicine University of Zürich

ronald.jung@zzm.uzh.ch0041 44 63433 11

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026